View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Martin Huseby Karlsen
  • Martin Huseby Karlsen

Muted 2025 growth expectations

Following Q1 earnings calls by some of the oil service companies, 2025 outlooks appear more challenging than previously. Baker Hughes expects international upstream spending to decline by mid- to high-single digits, while Halliburton sees its international revenues flat to slightly down. Furthermore, Weatherford expects 2025 international revenue to decline by low double- to mid-double digits. Precision Drilling flagged additional rig suspensions by Saudi Aramco, and SLB highlighted a slow start...

ABGSC Oil & Oil Services Research ... (+3)
  • ABGSC Oil & Oil Services Research
  • Njål Kleiven
  • Stian Wibstad
Martin Huseby Karlsen
  • Martin Huseby Karlsen

ENI capex cut but maintains shareholder returns

Driven by macro headwinds and uncertainty around trade tariffs, ENI was the first large oil company to introduce capex cuts for 2025, contributing to a more challenging business environment for oil services. Over the past five years, we estimate ENI to have been the oil major with strongest offshore spending growth, and it has been considered active and opportunistic while others have been more conservative. Hence, we see its reduction as a soft datapoint for oil services. ENI has optimised its ...

 PRESS RELEASE

Transocean Ltd. Announces Time Change for First Quarter 2025 Earnings ...

Transocean Ltd. Announces Time Change for First Quarter 2025 Earnings Call STEINHAUSEN, Switzerland, April 17, 2025 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) announced today that, due to a scheduling conflict, it is changing the time of its first quarter 2025 earnings call. It will now conduct the teleconference starting at 10 a.m. EDT, 4 p.m. CEST, on Tuesday, April 29, 2025. As previously announced, the company’s first quarter 2025 earnings will be reported on Monday, April 28, with the teleconference scheduled on Tuesday, April 29. Individuals who wish to participate in the call...

Martin Huseby Karlsen
  • Martin Huseby Karlsen

Welcomed tender from Petrobras

Updates suggest Petrobras yesterday launched a new tender for “one or more” deepwater rigs for the Buzios field starting late-2026/early-2027. As it has been a while since the last Petrobras tender, and there has been uncertainty related to the timing of upcoming tenders, we believe a new Petrobras tender would offer relief for investors. As we count nine rigs already contracted with Petrobras to match the start-up window, we expect the requirement would be filled by rigs already in the country,...

 PRESS RELEASE

Transocean Ltd. Provides Quarterly Fleet Status Report

Transocean Ltd. Provides Quarterly Fleet Status Report STEINHAUSEN, Switzerland, April 16, 2025 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) today issued a quarterly Fleet Status Report that provides the current status of, and contract information for, the company’s fleet of offshore drilling rigs. As of April 16, 2025, the company’s total backlog is approximately $7.9 billion.   The report can be accessed on the company’s website: . About Transocean Transocean is a leading international provider of offshore contract drilling services for oil and gas wells. Transocean specializes i...

Martin Huseby Karlsen
  • Martin Huseby Karlsen

Looking at required day-rates

Although there are several ongoing deepwater tenders, the lack of recent deepwater fixtures has created uncertainty among investors related to day-rates. Consequently, we have analysed the required day-rates to support current share prices and valuations. Given the high operating leverage and multiple variables involved (utilisation, lifetime and cost of capital), we estimate the sector requires 7G drillship day-rates from the mid-USD300k and above to support the current share prices.

 PRESS RELEASE

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan D...

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025 HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, today announced that Dr. David Young, Founder and President of Research & Development, has been invited to present at the World Orphan Drug Congress USA 2025. Dr. Young’s presentation, titled “Applying Principles of FDA’s Project Optimus to Oncol...

 PRESS RELEASE

Transocean Ltd. Announces First Quarter 2025 Earnings Release Date

Transocean Ltd. Announces First Quarter 2025 Earnings Release Date STEINHAUSEN, Switzerland, April 10, 2025 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) announced today that it will report earnings for the first quarter 2025 on Monday, April 28, 2025. The company will conduct a teleconference to discuss the results starting at 9 a.m. EDT, 3 p.m. CEST, on Tuesday, April 29, 2025. Individuals who wish to participate should dial approximately 15 minutes prior to the scheduled start time and refer to conference code 119877. The teleconference will be simulcast in a listen-only mode...

Martin Huseby Karlsen
  • Martin Huseby Karlsen

E&P spending sensitivity explored

With an oil price at the mid-USD60s/bbl level, focus on the oil major overspending situation, and resulting impact on the outlook for offshore-focused oil services, is set to increase further. While oil companies would likely cut, or even eliminate, buyback programmes first, we expect increased focus on spending reductions and efficiencies, creating a more challenging business environment for oil services. Hence, we see a risk of oil companies taking a more cautious approach, resulting in projec...

Martin Huseby Karlsen
  • Martin Huseby Karlsen

Pemex seeks national partnerships to accelerate developments

In line with its earlier communication about Pemex looking for partners to re-start drilling activities and fight oil production decline, local news reports suggest that Pemex is seeking partnerships for 17 blocks (11 offshore and six onshore) to secure external capital. It is mostly considering local partners and intends to take the role as operator in most of the blocks. At first glance, the expected volume from the partnerships looks to be small, with only 66kbd to be added by year-end 2025. ...

Martin Huseby Karlsen
  • Martin Huseby Karlsen

Valuation and market update

In this note, we show updated valuation and market statistics for the Offshore Drilling sector.

 PRESS RELEASE

MacroGenics Provides Update on Corporate Progress and 2024 Financial R...

MacroGenics Provides Update on Corporate Progress and 2024 Financial Results Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients with mCRPCInitiating new LINNET Phase 2 study of lorigerlimab in ovarian cancerAdvancing multiple novel topoisomerase 1 inhibitor-based ADCs, including MGC026, MGC028 and MGC030Discontinuing further internal clinical development of vobra duo; exploring potential partneringCash, cash equivalents and marketable securities of $201.7 million as of December 31, 2024; cash runway extended into the sec...

Martin Huseby Karlsen
  • Martin Huseby Karlsen

Deepwater fixture activity set to increase

After a slow start to the year for deepwater awards, we see long- and short-term jobs nearing rig selection. On the positive side, we believe the capital markets will appreciate increasing fixture activity and oil companies committing to long-term development jobs, supporting cycle duration. From a dayrate perspective, we see the bifurcation thesis unfolding, as some contractors are more focused on prioritising utilisation, also with counterparty, rig quality and region playing a role. Hence, as...

Martin Huseby Karlsen
  • Martin Huseby Karlsen

In a mid-cycle plateau

Following recent updates from E&P companies, we have reduced our 2025 offshore spending estimate to 0.5% (from c3% earlier this year). This is driven by a combination of actual 2024 spending being higher than expected (8% versus 4% previously), creating tougher comparables and a reduction in spending plans from Pemex in 2025. Despite growth flattening out, we still see the cycle building in duration, with execution of deepwater developments remaining on the agenda, albeit with a delayed executio...

 PRESS RELEASE

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharm...

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference HANOVER, Md., March 18, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, today announced its participation in the MedInvest Biotech and Pharma Investor Conference being held March 27-28, 2025, at Cooley’s law office in New York City. Management will present a corporate overview on Friday, March 28th at 9:40 a.m. Easte...

Martin Huseby Karlsen
  • Martin Huseby Karlsen

Valuation and market update

In this note, we show updated valuation and market statistics for the Offshore Drilling sector.

Martin Huseby Karlsen
  • Martin Huseby Karlsen

Valuation and market update

In this note, we show updated valuation and market statistics for the Offshore Drilling sector.

 PRESS RELEASE

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financ...

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call ROCKVILLE, MD, March 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the fourth quarter and full year of 2024 after the market closes on Thursday, March 20, 2025. MacroGenics will host a conference call to discuss the financial results and recent...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch